Defen Wang

521 total citations
34 papers, 394 citations indexed

About

Defen Wang is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Defen Wang has authored 34 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Genetics. Recurrent topics in Defen Wang's work include Sexual Differentiation and Disorders (8 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Magnetism in coordination complexes (5 papers). Defen Wang is often cited by papers focused on Sexual Differentiation and Disorders (8 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Magnetism in coordination complexes (5 papers). Defen Wang collaborates with scholars based in China, Hong Kong and United States. Defen Wang's co-authors include Hao Ying, John A. Phillips, Cindy L. Vnencak‐Jones, Hongwen Hu, Xiujuan Su, Xueya Cai, Yuping Tang, Yuhong Li, Yujie Chen and Yuan Xiao and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Chemical Communications.

In The Last Decade

Defen Wang

32 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Defen Wang China 12 137 112 77 70 58 34 394
Gülçin Altínok Türkiye 14 47 0.3× 169 1.5× 33 0.4× 45 0.6× 54 0.9× 38 921
I. F. Douek United Kingdom 5 108 0.8× 94 0.8× 55 0.7× 9 0.1× 62 1.1× 8 403
Wanqing Liu United States 14 38 0.3× 165 1.5× 30 0.4× 3 0.0× 140 2.4× 31 562
Joshua A. Levine United States 9 138 1.0× 80 0.7× 18 0.2× 4 0.1× 11 0.2× 24 325
Rita Sigüeiro Spain 11 67 0.5× 60 0.5× 90 1.2× 8 0.1× 18 0.3× 23 562
Yukiko Hasegawa Japan 10 150 1.1× 119 1.1× 30 0.4× 8 0.1× 46 0.8× 29 356
Sati C. Chattoraj United States 12 80 0.6× 52 0.5× 93 1.2× 37 0.5× 10 0.2× 33 347
Bénédicte Kiehr Denmark 8 208 1.5× 270 2.4× 76 1.0× 8 0.1× 52 0.9× 14 496
Julianne M. Davis United States 9 17 0.1× 254 2.3× 12 0.2× 13 0.2× 101 1.7× 10 485
Marie L. Smith United Kingdom 15 31 0.2× 164 1.5× 13 0.2× 4 0.1× 80 1.4× 44 586

Countries citing papers authored by Defen Wang

Since Specialization
Citations

This map shows the geographic impact of Defen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Defen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Defen Wang more than expected).

Fields of papers citing papers by Defen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Defen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Defen Wang. The network helps show where Defen Wang may publish in the future.

Co-authorship network of co-authors of Defen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Defen Wang. A scholar is included among the top collaborators of Defen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Defen Wang. Defen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Ying, Yao Yao, Xiang Fang, & Defen Wang. (2022). Clinical Practice of Danzhi Xiaoyao Powder. 4(4).
2.
3.
Li, Heng, et al.. (2020). β-Caryophyllene inhibits high glucose-induced oxidative stress, inflammation and extracellular matrix accumulation in mesangial cells. International Immunopharmacology. 84. 106556–106556. 35 indexed citations
4.
Yang, Lulu, Chenhui Zhang, Wei Wang, et al.. (2018). Pathogenic gene screening in 91 Chinese patients with short stature of unknown etiology with a targeted next-generation sequencing panel. BMC Medical Genetics. 19(1). 212–212. 21 indexed citations
5.
Ying, Hao, et al.. (2016). Effect of Placenta Previa on Preeclampsia. PLoS ONE. 11(1). e0146126–e0146126. 12 indexed citations
6.
Ying, Hao, Yuping Tang, Xiujuan Su, et al.. (2016). Maternal TSH level and TPOAb status in early pregnancy and their relationship to the risk of gestational diabetes mellitus. Endocrine. 54(3). 742–750. 67 indexed citations
7.
Chang, Guoying, et al.. (2012). The analysis of clinical manifestations and genetic mutations in Chinese boys with primary adrenal insufficiency. Journal of Pediatric Endocrinology and Metabolism. 25(3-4). 295–300. 10 indexed citations
8.
Wang, Ruifang, Zhiya Dong, Wei Wang, et al.. (2011). Effects of recombinant human growth hormone on final adult height in children with Turner′s syndrome and analysis of the influencing factors. Zhonghua neifenmi daixie zazhi. 27(11). 901–905. 1 indexed citations
9.
Xiao, Yuan, Zhiya Dong, Wenli Lu, et al.. (2011). Measurement of amino-terminal propeptide of C-type natriuretic peptide in patients with idiopathic short stature or isolated growth hormone deficiency. Journal of Pediatric Endocrinology and Metabolism. 24(11-12). 989–94. 9 indexed citations
10.
Xiao, Yuan, Defen Wang, M Kellis, Jun Yang, & Wei Wang. (2010). S578N mutation of the androgen receptor in an adolescent with complete androgen insensitivity syndrome.. PubMed. 123(11). 1473–6. 2 indexed citations
11.
Lu, Wenli, et al.. (2010). [Relationship between the polymorphism of growth hormone receptor Ex3 and the efficacy of rhGH treatment in children with idiopathic short stature].. PubMed. 12(9). 730–3. 1 indexed citations
12.
Chang, Guoying, Zhiya Dong, Wei Wang, & Defen Wang. (2010). [Long-term follow-up of isolated-growth hormone deficiency typeIA: the clinical analysis of 2-sister cases].. PubMed. 48(12). 944–6. 1 indexed citations
13.
Wang, Wei, et al.. (2005). [Oral glucose tolerance and insulin release test in 52 cases of obese and overweight children].. PubMed. 43(2). 93–5. 1 indexed citations
14.
Wang, Wei, Defen Wang, Zhiya Dong, et al.. (2003). [Prader-Willi syndrome and genomic imprinting].. PubMed. 41(6). 453–6. 1 indexed citations
15.
Lü, Guoqiang, et al.. (2002). [Detection of fibroblast growth factor receptor 3 gene mutation at nucleotide 1138 site in congenita achondroplasia patients].. PubMed. 19(3). 205–8. 3 indexed citations
16.
Lü, Guoqiang, et al.. (1998). FGFR3 Gene Mutations in Transmembrane Domain in Chinese Achondroplasia and Hypochondroplasia Patients. Hormone Research. 49(Suppl. 1). 57–57. 1 indexed citations
17.
18.
19.
Fu, You‐Jun, Jie Sun, Qi Li, et al.. (1996). Substituent-controlled assembly of helical complexes: synthesis, crystal and molecular structures of double helical silver(I) complexes with substituted quinquepyridines. Journal of the Chemical Society Dalton Transactions. 2309–2309. 21 indexed citations
20.
Vnencak‐Jones, Cindy L., John A. Phillips, & Defen Wang. (1990). Use of Polymerase Chain Reaction in Detection of Growth Hormone Gene Deletions*. The Journal of Clinical Endocrinology & Metabolism. 70(6). 1550–1553. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gülçin Altínok Breakdown of academic impact, for papers by I. F. Douek Breakdown of academic impact, for papers by Wanqing Liu Breakdown of academic impact, for papers by Joshua A. Levine Breakdown of academic impact, for papers by Rita Sigüeiro Breakdown of academic impact, for papers by Yukiko Hasegawa Breakdown of academic impact, for papers by Sati C. Chattoraj Breakdown of academic impact, for papers by Bénédicte Kiehr Breakdown of academic impact, for papers by Julianne M. Davis Breakdown of academic impact, for papers by Marie L. Smith
Rankless by CCL
2026